The use of conventional disease-modifying anti-rheumatic drugs in established RA

Best Practice and Research: Clinical Rheumatology

Volumn 25, Issue 4, 2011, Pages 523-533

  Jurgens, M S ^a   Jacobs, J W G ^a   Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Combination strategy; DMARD; Established RA; Glucocorticoids; Rheumatoid arthritis; Tight control; Treat to target

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; AZATHIOPRINE; CHLOROQUINE; CORTICOTROPIN; CYCLOSPORIN; DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLD; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TETRACOSACTIDE;

DRUG EFFICACY; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG TOLERABILITY; HUMAN; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG MONITORING; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; METHOTREXATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 82955227633     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2011.10.006     Document Type: Review

References (83)

1. D.L. Scott, F. Wolfe, and T.W. Huizinga Rheumatoid arthritis Lancet 376 2010 1094 1108
2. P.G. Conaghan, M.J. Green, and P. Emery Established rheumatoid arthritis Baillire's Best Practice & Research. Clinical Rheumatology 13 1999 561 575 (Pubitemid 30050428)
3. J.R. Ward Challenging the pyramid. A new look at therapeutic approaches for rheumatoid arthritis. Earlier intervention with second line therapies Journal of Rheumatology Supplement 25 1990 18 23
4. W.A. Katz Challenging the pyramid. A new look at therapeutic approaches for rheumatoid arthritis. Patient selection Journal of Rheumatology Supplement 25 1990 39 41
5. A. van der Heide, J.W. Jacobs, and J.W. Bijlsma The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial Annals of Internal Medicine 124 1996 699 707
6. D. Aletaha, V. Strand, J.S. Smolen, and M.M. Ward Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results Annals of the Rheumatic Diseases 67 2008 238 243 (Pubitemid 351183315)
7. K.R. Wilske, and L.A. Healey Remodeling the pyramid-a concept whose time has come Journal of Rheumatology 16 1989 565 567
8. S. Irvine, R. Munro, and D. Porter Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice Annals of the Rheumatic Diseases 58 1999 510 513 (Pubitemid 29359497)
9. S.M. Verstappen, J.W. Jacobs, and J.W. Bijlsma The Utrecht experience with different treatment strategies in early rheumatoid arthritis Clinical & Experimental Rheumatology 21 2003 S165 S168 (Pubitemid 37265607)
10. W. Katchamart, J. Bourre-Tessier, and T. Donka Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis Journal of Rheumatology 37 2010 1422 1430
11. M.F. Bakker, J.W. Jacobs, S.M. Verstappen, and J.W. Bijlsma Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility Annals of the Rheumatic Diseases 66 Suppl. 3 2007 iii56 iii60
12. M. Schoels, R. Knevel, and D. Aletaha Evidence for treating rheumatoid arthritis to target: results of a systematic literature search Annals of the Rheumatic Diseases 69 2010 638 643
13. F.C. Breedveld, and B. Combe Understanding emerging treatment paradigms in rheumatoid arthritis Arthritis Research & Therapy 13 Suppl. 1 2011 S3
14. N.B. Klarenbeek, C.F. Allaart, and P.J. Kerstens The BeSt story: on strategy trials in rheumatoid arthritis Current Opinion in Rheumatology 21 2009 291 298
15. J. Dale, and D. Porter Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritis Best Practice & Research: Clinical Rheumatology 24 2010 443 455
16. J.S. Smolen, D. Aletaha, and J.W. Bijlsma Treating rheumatoid arthritis to target: recommendations of an international task force Annals of the Rheumatic Diseases 69 2010 631 637
17. NICE-guidance 2009 http://guidance.nice.org.uk/CG79/Guidance/pdf/English
18. K.G. Saag, G.G. Teng, and N.M. Patkar American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis Arthritis & Rheumatism 59 2008 762 784 (Pubitemid 351847559)
19. J.S. Smolen, R. Landewe, and F.C. Breedveld EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs Annals of the Rheumatic Diseases 69 2010 964 975
20. Resman-Targoff BH, Cicero MP. Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals. American Journal of Managed Care;16:S249-S258.
21. J.W. Bijlsma, M.C. van der Goes, and J.N. Hoes Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy Annals of the New York Academy of Sciences 1193 2010 123 126
22. H.E. Paulus Defining remission in rheumatoid arthritis: what is it? Does it matter? Journal of Rheumatology 31 2004 1 4 (Pubitemid 38067511)
23. T. Sokka, M. Envalds, and T. Pincus Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs Modern Rheumatology 18 2008 228 239
24. B. Saleem, S. Nizam, and P. Emery Can remission be maintained with or without further drug therapy in rheumatoid arthritis? Clinical & Experimental Rheumatology 24 2006 S-33 S-36
25. D.T. Felson, J.S. Smolen, and G. Wells American College of Rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials Arthritis and Rheumatism 63 2011 573 586
26. W. Katchamart, J. Trudeau, V. Phumethum, and C. Bombardier Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis Annals of the Rheumatic Diseases 68 2009 1105 1112
27. C.H. van Jaarsveld, J.W. Jacobs, and M.J. van der Veen Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands Annals of the Rheumatic Diseases 59 2000 468 477 (Pubitemid 30395605)
28. W. Katchamart, J. Trudeau, V. Phumethum, and C. Bombardier Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis Cochrane Database of Systematic Reviews 2010 CD008495
29. T. Pincus, Y. Yazici, and T. Sokka Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis Clinical & Experimental Rheumatology 21 2003 S179 S185 (Pubitemid 37265610)
30. M.F. Bakker, J.W. Jacobs, and P.M. Welsing Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study Annals of the Rheumatic Diseases 69 2010 1849 1852
31. Verstappen SM, Bakker MF, Heurkens AH, et al. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study. Annals of the Rheumatic Diseases; 69: 1044-1048.
32. Bakker MF, Jacobs JW, Welsing PM, et al. Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study. Annals of the Rheumatic Diseases; 70: 1099-1103.
33. T. Rath, and A. Rubbert Drug combinations with methotrexate to treat rheumatoid arthritis Clinical & Experimental Rheumatology 28 2010 S52 S57
34. O. Singer, and A. Gibofsky Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011? Current Opinion in Rheumatology 23 2011 288 292
35. I.B. McInnes, J.W. Jacobs, J. Boodburn, and J.M. van Laar Treatment of rheumatoid arthritis J.W.J. Bijlsma, Eular Compendium on Rheumatic Diseases 2009 BMJ Publishing Group Ltd London 81 91
36. M. Osiri, B. Shea, and V. Robinson Leflunomide for treating rheumatoid arthritis Cochrane Database of Systematic Reviews 2003 CD002047
37. J.N. Hoes, J.W. Jacobs, F. Buttgereit, and J.W. Bijlsma Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis Nature Reviews Rheumatology 6 2010 693 702
38. B. Svensson, A. Boonen, and K. Albertsson Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial Arthritis and Rheumatism 52 2005 3360 3370 (Pubitemid 41612202)
39. I. Hafstrom, K. Albertsson, and A. Boonen Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study Annals of the Rheumatic Diseases 68 2009 508 513
40. A.A. van Everdingen, J.W. Jacobs, D.R. Siewertsz Van Reesema, and J.W. Bijlsma Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial Annals of Internal Medicine 136 2002 1 12 (Pubitemid 34038692)
41. J.R. Kirwan, J.W. Bijlsma, M. Boers, and B.J. Shea Effects of glucocorticoids on radiological progression in rheumatoid arthritis Cochrane Database of Systematic Reviews 2007 CD006356
42. K.E. Donahue, G. Gartlehner, and D.E. Jonas Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis Annals of Internal Medicine 148 2008 124 134 (Pubitemid 351651555)
43. E.H. Choy, C. Smith, C.J. Dore, and D.L. Scott A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal Rheumatology (Oxford) 44 2005 1414 1421 (Pubitemid 41631866)
44. M. Boers, and M. Ramsden Long acting drug combinations in rheumatoid arthritis: a formal overview Journal of Rheumatology 18 1991 316 324
45. D.T. Felson, J.J. Anderson, and R.F. Meenan The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis Arthritis and Rheumatism 37 1994 1487 1491 (Pubitemid 24337692)
46. M.C. Hochberg, J.K. Tracy, and R.H. Flores Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate Annals of the Rheumatic Diseases 60 Suppl. 3 2001 iii51 iii514
47. I. van Beusekom, C. Maclean, C.F. Allaart, and F.C. Breedveld Systematic Review of combination DMARD therapy in rheumatoid arthritis Rand Europe 2000 RE-2000.14
48. A.C. Verhoeven, M. Boers, and P. Tugwell Combination therapy in rheumatoid arthritis: updated systematic review British Journal of Rheumatology 37 1998 612 619
49. L.G. Schipper, and P.L. van Riel Ups and downs in the treatment strategies of rheumatoid arthritis Rheumatology (Oxford) 50 2011 818 820
50. Y.P. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, and C.F. Allaart Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial Arthritis and Rheumatism 58 2008 S126 S135
51. J.M. Kremer, M.C. Genovese, and G.W. Cannon Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial Annals of the Rheumatic Diseases 137 2002 726 733 (Pubitemid 35265316)
52. J. Kremer, M. Genovese, and G.W. Cannon Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial Journal of Rheumatology 31 2004 1521 1531 (Pubitemid 39006632)
53. P. Tugwell, T. Pincus, and D. Yocum Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group The New England Journal of Medicine 333 1995 137 141
54. C.M. Stein, T. Pincus, and D. Yocum Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine combination study group Arthritis & Rheumatism 40 1997 1843 1851 (Pubitemid 27452536)
55. M.L. Hetland, K. Stengaard-Pedersen, and P. Junker Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study Arthritis & Rheumatism 54 2006 1401 1409
56. M.L. Hetland, K. Stengaard-Pedersen, and P. Junker Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study Annals of the Rheumatic Diseases 67 2008 815 822 (Pubitemid 351829382)
57. M.L. Hetland, K. Stengaard-Pedersen, and P. Junker Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial Annals of the Rheumatic Diseases 69 2010 1789 1795
58. S.J. Carmichael, J. Beal, R.O. Day, and S.E. Tett Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate Journal of Rheumatology 29 2002 2077 2083
59. J.R. O'Dell, R. Leff, and G. Paulsen Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial Arthritis & Rheumatism 46 2002 1164 1170 (Pubitemid 34525821)
60. C.J. Haagsma, P.L. van Riel, A.J. de Jong, and L.B. van de Putte Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial British Journal of Rheumatology 36 1997 1082 1088
61. T.T. Mottonen, P.J. Hannonen, and M. Boers Combination DMARD therapy including corticosteroids in early rheumatoid arthritis Clinical & Experimental Rheumatology 17 1999 S59 S65 (Pubitemid 29503359)
62. H.A. Capell, R. Madhok, and D.R. Porter Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study Annals of the Rheumatic Diseases 66 2007 235 241 (Pubitemid 46226060)
63. J.R. O'Dell, C.E. Haire, and N. Erikson Treatment of Rheumatoid Arthritis with Methotrexate alone, Sulfasalazine and Hydroxychloroquine, or a combination of all three medications The New England Journal of Medicine 334 1996 1287 1291 (Pubitemid 26138009)
64. F. Buttgereit, J.A. da Silva, and M. Boers Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology Annals of the Rheumatic Diseases 61 2002 718 722 (Pubitemid 34787710)
65. S. Wassenberg, R. Rau, P. Steinfeld, and H. Zeidler Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial Arthritis & Rheumatism 52 2005 3371 3380 (Pubitemid 41612203)
66. M.F. Bakker, J.W. Jacobs, P.M. Welsing, S.M. Verstappen, J. Tekstra, E. Ton, and M.A. Geurts Low-dose prednisone inclusion into a MTX-based tight control strategy for early rheumatoid arthritis: better control of disease and erosive joint damage. Results from the double-blind randomized CAMERA-II trial Annals of the Rheumatic Diseases 70 Suppl. 3 2011 114
67. M. Boers, A.C. Verhoeven, and H.M. Markusse Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet 350 1997 309 318 (Pubitemid 27351112)
68. J.W. Jacobs, A.A. van Everdingen, S.M. Verstappen, and J.W. Bijlsma Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo Arthritis & Rheumatism 54 2006 1422 1428
69. R.B. Landewe, M. Boers, and A.C. Verhoeven COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention Arthritis & Rheumatism 46 2002 347 356 (Pubitemid 34136571)
70. L.H. van Tuyl, M. Boers, and W.F. Lems Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis Annals of the Rheumatic Diseases 69 2010 807 812
71. A.A. van Everdingen, D.R. Siewertsz van Reesema, J.W. Jacobs, and J.W. Bijlsma The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies Arthritis & Rheumatism 51 2004 233 238 (Pubitemid 38468707)
72. O.A. Malysheva, M. Wahle, and U. Wagner Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs Journal of Rheumatology 35 2008 979 985 (Pubitemid 351813140)
73. P. Emery, R. Fleischmann, and A. Filipowicz-Sosnowska The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial Arthritis & Rheumatism 54 2006 1390 1400
74. J. Augustsson, S. Eksborg, and S. Ernestam Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 66 2007 1462 1466 (Pubitemid 350032653)
75. M.J. van der Veen, and J.W. Bijlsma The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis Clinical Rheumatology 12 1993 500 505 (Pubitemid 24021294)
76. G. Mouterde, E. Dernis, and A. Ruyssen-Witrand Indications of glucocorticoids in early arthritis and rheumatoid arthritis: recommendations for clinical practice based on data from the literature and expert opinion Joint Bone Spine 77 2010 597 603
77. J.W. Jacobs, R. Geenen, and A.W. Evers Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis Annals of the Rheumatic Diseases 60 2001 61 64 (Pubitemid 32038955)
78. E.H. Choy, G.H. Kingsley, and B. Khoshaba A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs Annals of the Rheumatic Diseases 64 2005 1288 1293 (Pubitemid 41206244)
79. W.J. Taylor, C.N. Rajapakse, and K.A. Harris Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup Journal of Rheumatology 26 1999 2544 2550
80. M. Radia, and D.E. Furst Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis Journal of Rheumatology 15 1988 242 246 (Pubitemid 18073746)
81. M.D. Smith, M.J. Ahern, and P.J. Roberts-Thomson Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? Annals of the Rheumatic Diseases 47 1988 28 33 (Pubitemid 18054517)
82. C.J. Needs, M. Smith, and J. Boutagy Comparison of methylprednisolone (1 g i.v.) with prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study Journal of Rheumatology 15 1988 224 228 (Pubitemid 18073742)
83. P.J. Hayball, D.G. Cosh, and M.J. Ahern High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response European Journal of Clinical Pharmacology 42 1992 85 88